We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.

For more information visit our privacy policy.

Common Contracts

10 similar Underwriting Agreement contracts by Oculus Innovative Sciences, Inc., Celsius Holdings, Inc., Opexa Therapeutics, Inc., others

MEDICINOVA, INC. 2,750,000 Units Each Unit consisting of One Share of Common Stock and a Warrant to Purchase One Share of Common Stock UNDERWRITING AGREEMENT March 23, 2011
Underwriting Agreement • March 24th, 2011 • Medicinova Inc • Pharmaceutical preparations • New York
ARMOUR Residential REIT, Inc. 7,000,000 Shares of Common Stock UNDERWRITING AGREEMENT
Underwriting Agreement • June 1st, 2010 • Armour Residential REIT, Inc. • Real estate investment trusts • New York

ARMOUR Residential REIT, Inc. (the “Company”), a Maryland corporation that is externally managed by ARMOUR Residential Management LLC (the “Manager”), proposes to issue and sell to the several Underwriters (as defined below) an aggregate of 7,000,000 shares (the “Shares”) of its common stock, $0.001 par value per share (the “Common Stock”), pursuant to and in accordance with the terms and conditions of this underwriting agreement (the “Agreement”).

900,000 Units CELSIUS HOLDINGS, INC. Each Unit consisting of Four Shares of Common Stock and One Warrant, each to Purchase One Share of Common Stock UNDERWRITING AGREEMENT
Underwriting Agreement • February 8th, 2010 • Celsius Holdings, Inc. • Bottled & canned soft drinks & carbonated waters • New York

CELSIUS HOLDINGS, INC, a Nevada corporation (the “Company”), proposes to issue and sell to the several Underwriters (as defined below) an aggregate of (i) 3,600,000 shares (the “Shares”) of its common stock, $0.001 par value per share (the “Common Stock”) and (ii) warrants (the “Warrants”) to purchase up to an aggregate of 900,000 shares of Common Stock (the “Warrant Shares”) pursuant to and in accordance with the terms and conditions of this underwriting agreement (the “Agreement”). The Shares and Warrants shall be sold in units (each a “Unit”), each Unit consisting of four (4) Shares and one (1) Warrant, each to purchase one (1) Warrant Share at the exercise price per share specified in the Prospectus (as defined below). The Shares and the Warrants shall be issued separately and shall be transferable separately immediately upon issuance. The Warrants will be issued pursuant to the terms of a Warrant Agreement (the “Warrant Agreement”) to be entered into by and between the Company and

900,000 Units CELSIUS HOLDINGS, INC. Each Unit consisting of Four Shares of Common Stock and One Warrant, each to Purchase One Share of Common Stock UNDERWRITING AGREEMENT
Underwriting Agreement • January 22nd, 2010 • Celsius Holdings, Inc. • Bottled & canned soft drinks & carbonated waters • New York

CELSIUS HOLDINGS, INC, a Nevada corporation (the “Company”), proposes to issue and sell to the several Underwriters (as defined below) an aggregate of (i) 3,600,000 shares (the “Shares”) of its common stock, $0.001 par value per share (the “Common Stock”) and (ii) warrants (the “Warrants”) to purchase up to an aggregate of 900,000 shares of Common Stock (the “Warrant Shares”) pursuant to and in accordance with the terms and conditions of this underwriting agreement (the “Agreement”). The Shares and Warrants shall be sold in units (each a “Unit”), each Unit consisting of four (4) Shares and one (1) Warrant, each to purchase one (1) Warrant Share at the exercise price per share specified in the Prospectus (as defined below). The Shares and the Warrants shall be issued separately and shall be transferable separately immediately upon issuance. The Warrants will be issued pursuant to the terms of a Warrant Agreement (the “Warrant Agreement”) to be entered into by and between the Company and

4,000,000 Shares HUIHENG MEDICAL, INC. Common Stock UNDERWRITING AGREEMENT
Underwriting Agreement • August 29th, 2008 • Huiheng Medical, Inc. • Surgical & medical instruments & apparatus • New York

This is to confirm the agreement concerning the purchase of the Securities from the Company and the Selling Stockholders by the Underwriters.

3,500,000 Shares and 3,500,000 Warrants OPEXA THERAPEUTICS, INC. Common Stock and Common Stock Purchase Warrants UNDERWRITING AGREEMENT February 13, 2008
Underwriting Agreement • February 14th, 2008 • Opexa Therapeutics, Inc. • Pharmaceutical preparations • California
4,500,000 Shares and 4,500,000 Warrants OPEXA THERAPEUTICS, Inc. Common Stock and Common Stock Purchase Warrants UNDERWRITING AGREEMENT
Underwriting Agreement • December 20th, 2007 • Opexa Therapeutics, Inc. • Pharmaceutical preparations • California

Opexa Therapeutics, Inc., a Texas corporation (“Company”), proposes to issue and sell to the several Underwriters (as defined below) an aggregate of 4,500,000 shares of its common stock, $0.50 par value per share (the “Common Stock”) and an aggregate of 4,500,000 common stock purchase warrants, each warrant to purchase one share of common stock for an exercise period of five years commencing the date of issuance (the “Public Series E Warrants”).

4,025,000 Shares OCULUS INNOVATIVE SCIENCES, INC. Common Stock UNDERWRITING AGREEMENT
Underwriting Agreement • January 3rd, 2007 • Oculus Innovative Sciences, Inc. • Surgical & medical instruments & apparatus • California

Roth Capital Partners, LLC As Representative of the Several Underwriters named in Schedule I hereto 24 Corporate Plaza Newport Beach, CA 92660

3,538,461 Shares OCULUS INNOVATIVE SCIENCES, INC. Common Stock UNDERWRITING AGREEMENT
Underwriting Agreement • December 20th, 2006 • Oculus Innovative Sciences, Inc. • Surgical & medical instruments & apparatus • California

Roth Capital Partners, LLC As Representative of the Several Underwriters named in Schedule I hereto 24 Corporate Plaza Newport Beach, CA 92660

3,538,461 Shares OCULUS INNOVATIVE SCIENCES, INC. Common Stock UNDERWRITING AGREEMENT
Underwriting Agreement • December 18th, 2006 • Oculus Innovative Sciences, Inc. • Surgical & medical instruments & apparatus • California

Roth Capital Partners, LLC As Representative of the Several Underwriters named in Schedule I hereto 24 Corporate Plaza Newport Beach, CA 92660